by Bruce Sylvester – New “real world” data suggests that the efficacy of Remsima® (infliximab), a biosimilar monoclonal antibody (mAb) anti-TNF-alpha agent approved by the European Commission, is… read more.
by Bruce Sylvester: Researchers report that 90% of subjects with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies have achieved… read more.
by Bruce Sylvester: Patients with familial hypercholesterolaemia (FH) who are being treated with statins have achieved additional lowering of LDL cholesterol with adjuvant evolocumab therapy, researchers reported on… read more.
by Bruce Sylvester: Gout is associated with an increased risk of developing type 2 diabetes, researchers reported on Oct 2, 2014 in the British Medical Journal/BMJ. And the… read more.
by Bruce Sylvester – Compared with monotherapy with long-acting beta-agonists (LABAs), combination therapy with LABAs and inhaled corticosteroids (ICSs) among older adults with chronic obstructive pulmonary disease (COPD),… read more.
by Bruce Sylvester – Researchers report that metformin therapy, a treatment for type 2 diabetes, could induce a lowering thyroid-stimulating hormone (TSH) in patients with underactive thyroids (hypothyroidism)…. read more.
by Bruce Sylvester – Following heart attack, patients who undergo revascularization of all significantly blocked arteries achieve better outcomes than patients who undergo revascularization of the “culprit” artery… read more.
by Bruce Sylvester – Researchers from first large randomized trial comparing paracetamol with placebo for lower back pain report that paracetamol did not excel placebo at hastening recovery… read more.
by Bruce Sylvester – Compared to no screening, flexible sigmoidoscopy screening has resulted in a reduced incidence of colorectal cancer and rate of death from colorectal cancer, researchers… read more.
by Bruce Sylvester – Researchers report that drug therapy for ADHD does not increase the risk of suicide attempts or suicide. The findings were published on June 18,… read more.
by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
by Bruce Sylvester: After 13 months of high-dose statin therapy, STEMI (ST Segment Elevation Myocardial Infarction) patients achieved significant reductions in coronary atherosclerosis, researchers reported on Sept. 2,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
